Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Drug Delivery
|
November 8, 2021
Ion-dependent slow protein release from <i>in vivo</i> disintegrating micro-granules
Patricia Álamo, Eloi Parladé, Hèctor López-Laguna, et al.
International Journal of Pharmaceutics
|
January 11, 2026
Subcutaneous administration of an endocrine-mimetic platform allows for prolonged tumor uptake of a tumor targeting protein
Patricia Álamo, Hèctor López-Laguna, Marianna T P Favaro, et al.
Cancers
|
January 8, 2023
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models
Esperanza Medina-Gutiérrez, Annabel García-León, Alberto Gallardo, et al.
ACS Applied Materials & Interfaces
|
August 24, 2023
Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins
Patricia Álamo, Eloi Parladé, Marianna T P Favaro, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 19, 2024
Structural Stabilization of Clinically Oriented Oligomeric Proteins During their Transit through Synthetic Secretory Amyloids
Julieta M Sánchez, Hèctor López-Laguna, Eloi Parladé, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 7, 2018
Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs
Laura Sánchez-García, Naroa Serna, Patricia Álamo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 14, 2020
Nanostructured toxins for the selective destruction of drug-resistant human CXCR4<sup>+</sup> colorectal cancer stem cells
Naroa Serna, Patricia Álamo, Prashanthi Ramesh, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 12, 2020
Artificial Inclusion Bodies for Clinical Development
Julieta M Sánchez, Hèctor López-Laguna, Patricia Álamo, et al.
Theranostics
|
May 7, 2020
Selective delivery of T22-PE24-H6 to CXCR4<sup>+</sup> diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
Aïda Falgàs, Victor Pallarès, Naroa Serna, et al.
Acta Biomaterialia
|
July 1, 2020
A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity
Laura Sánchez-García, Rita Sala, Naroa Serna, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Drug Delivery
|
November 8, 2021
Ion-dependent slow protein release from <i>in vivo</i> disintegrating micro-granules
Patricia Álamo, Eloi Parladé, Hèctor López-Laguna, et al.
International Journal of Pharmaceutics
|
January 11, 2026
Subcutaneous administration of an endocrine-mimetic platform allows for prolonged tumor uptake of a tumor targeting protein
Patricia Álamo, Hèctor López-Laguna, Marianna T P Favaro, et al.
Cancers
|
January 8, 2023
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models
Esperanza Medina-Gutiérrez, Annabel García-León, Alberto Gallardo, et al.
ACS Applied Materials & Interfaces
|
August 24, 2023
Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins
Patricia Álamo, Eloi Parladé, Marianna T P Favaro, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 19, 2024
Structural Stabilization of Clinically Oriented Oligomeric Proteins During their Transit through Synthetic Secretory Amyloids
Julieta M Sánchez, Hèctor López-Laguna, Eloi Parladé, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 7, 2018
Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs
Laura Sánchez-García, Naroa Serna, Patricia Álamo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 14, 2020
Nanostructured toxins for the selective destruction of drug-resistant human CXCR4<sup>+</sup> colorectal cancer stem cells
Naroa Serna, Patricia Álamo, Prashanthi Ramesh, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 12, 2020
Artificial Inclusion Bodies for Clinical Development
Julieta M Sánchez, Hèctor López-Laguna, Patricia Álamo, et al.
Theranostics
|
May 7, 2020
Selective delivery of T22-PE24-H6 to CXCR4<sup>+</sup> diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
Aïda Falgàs, Victor Pallarès, Naroa Serna, et al.
Acta Biomaterialia
|
July 1, 2020
A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity
Laura Sánchez-García, Rita Sala, Naroa Serna, et al.
Page
of 4